(S1 (S (NP (NP (JJ Transient) (NN Transfection)) (PP (IN of) (NP (JJ Primary) (JJ Human) (NNS Monocytes))))))
(S1 (S (S (NP (NNS Monocytes)) (VP (VBD were) (VP (VBN transfected) (S (VP (VBG using) (NP (NP (DT the) (JJ human) (NN monocyte) (NN Amaxa) (NN nucleofector) (NN kit)) (PRN (-LRB- -LRB-) (NP (NNP Lonza) (NNP Walkersville) (NNP Inc) (, ,) (NNP Walkersville) (, ,) (NNP MD)) (-RRB- -RRB-))) (PP (IN as) (ADJP (ADJP (RB previously) (VBN described)) (PRN (-LRB- -LSB-) (NP (CD 51)) (-RRB- -RSB-))))))))) (. .)))
(S1 (S (ADVP (RB Briefly)) (, ,) (S (S (NP (NNS monocytes)) (VP (VBD were) (VP (VBN resuspended) (PP (IN in) (NP (NNP Amaxa) (NNP Nucleofactor) (NN solution))) (PP (IN at) (NP (NP (DT a) (NN density)) (PP (IN of) (NP (CD 20x106) (NNS cells/ml)))))))) (, ,) (CC and) (S (NP (NP (CD 2) (NN microg)) (PP (IN of) (NP (NP (JJ total) (NN plasmid) (NN DNA)) (ADJP (CD 100) (NN nM)))) (PP (IN of) (NP (NP (NN PKCalpha) (NN siRNA)) (CC or) (NP (NN control) (NN siRNA))))) (VP (VBD was) (VP (VP (VBN added)) (CC and) (VP (VBN transfected) (S (VP (VBG using) (NP (NN program) (NN Amaxa) (NN Y-01))))))))) (. .)))
(S1 (S (S (PP (IN For) (NP (NN co-transfection) (NNS studies))) (, ,) (NP (NP (NP (NN PKCalpha)) (CC or) (NP (NN NF-kappaB) (NN p65))) (NNS constructs)) (VP (VBD were) (VP (VBN mixed) (PP (IN at) (NP (NP (DT a) (NN ratio)) (PP (IN of) (NP (NN 5:1))) (PP (IN with) (NP (DT the) (NN reporter) (NN plasmid)))))))) (. .)))
(S1 (S (PP (ADVP (RB Immediately)) (IN after) (NP (NN transfection))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN washed) (PP (IN with) (NP (NP (CD 1) (NN ml)) (PP (IN of) (NP (NP (NP (NN RPMI) (NN medium)) (VP (VBG containing) (NP (NP (ADJP (CD 2) (NN mM)) (NN glutamine)) (CC and) (NP (ADJP (CD 10) (NN %)) (NN FBS))))) (CC or) (NP (NP (NN serum) (JJ free) (NN LGM) (NN medium)) (PRN (-LRB- -LRB-) (NP (NNP Lonza) (NNP Walkersville) (NNP Inc.)) (-RRB- -RRB-)))))))) (ADVP (RB then)) (VP (VBN plated) (PP (IN at) (NP (NP (CD 4x105) (NN cells/well)) (PP (IN in) (NP (JJ 24-well) (NNS plates))))))) (. .)))
(S1 (S (S (NP (DT The) (JJ original) (NN medium)) (VP (VBD was) (VP (VBN replaced) (PP (IN by) (NP (ADJP (NN serum) (JJ free)) (NN LGM) (NN medium))) (PP (IN without) (CC or) (PP (IN with) (NP (NP (NP (NN M-CSF)) (PRN (-LRB- -LRB-) (NP (CD 100) (NN ng/ml)) (-RRB- -RRB-))) (ADJP (NP (CD one) (NN hour)) (JJR later)))))))) (. .)))
(S1 (S (S (S (NP (DT The) (JJ next) (NN day))) (, ,) (NP (JJ cell-free) (NNS supernatants)) (VP (VBD were) (VP (VBN collected) (PP (IN for) (NP (DT the) (NN SEAP) (NN analysis)))))) (. .)))
(S1 (S (S (NP (NNS Cells)) (VP (VBD were) (VP (VBN stained) (PP (IN with) (NP (NP (NN Annexin) (NN V/propidium) (NN iodide)) (PRN (-LRB- -LRB-) (NP (NN PI)) (-RRB- -RRB-))))))) (. .)))
(S1 (S (S (PP (IN For) (NP (DT the) (NN inhibition) (NNS studies))) (, ,) (NP (NNS cells)) (VP (VBD were) (VP (VBN pre-incubated) (PP (IN with) (NP (NP (NN inhibitor)) (PP (IN for) (NP (NP (CD 30) (NNS minutes)) (PP (IN in) (NP (NP (JJ X-vivo) (NN medium)) (ADJP (JJ prior) (PP (TO to) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN M-CSF))))))))))))))) (. .)))
